BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38815860)

  • 1. Identification and Characterization of Rotigotine Degradation Products by HPLC Coupled DAD and CAD Detectors and HRMS Through Q-Orbitrap and Electrospray Ionization.
    Mendes TC; Viana GM; de Abreu LCL; Anselmo CS; Pereira HMG; da Silva AJR; Cabral LM; de Sousa VP
    J Pharm Sci; 2024 May; ():. PubMed ID: 38815860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC/Q-TOF-MS-based structural characterization of enasidenib degradation products and establishment of a stability-indicating assay method: Insights into chemical stability.
    Chakkar A; Chaturvedi S; Rajput N; Sengupta P; Sharma N
    Rapid Commun Mass Spectrom; 2024 Mar; 38(5):e9696. PubMed ID: 38355880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway.
    Mehta L; Naved T; Grover P; Bhardwaj M; Mukherjee D
    J Pharm Biomed Anal; 2021 Feb; 194():113768. PubMed ID: 33279300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of degradation products of macitentan under various stress conditions using liquid chromatography/mass spectrometry.
    Yerra NV; Pallerla P; Pandeti S; Tabet JC; Thota JR
    Rapid Commun Mass Spectrom; 2018 Jul; 32(13):1075-1084. PubMed ID: 29660192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of forced degradation products of sertraline hydrochloride using UPLC, ultra-high-performance liquid Chromatography-Quadrupole-Time of flight mass spectrometry (UHPLC-Q-TOF/MS/MS) and NMR.
    Grover P; Bhardwaj M; Mukherjee D
    J Pharm Biomed Anal; 2022 Nov; 221():115045. PubMed ID: 36126615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid chromatography/electrospray ionization tandem mass spectrometry study of repaglinide and its forced degradation products.
    Purna Chander C; Raju B; Ramesh M; Shankar G; Srinivas R
    Rapid Commun Mass Spectrom; 2018 Aug; 32(15):1181-1190. PubMed ID: 29723439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability-indicating assay method for determination of actarit, its process related impurities and degradation products: Insight into stability profile and degradation pathways
    Abiramasundari A; Joshi RP; Jalani HB; Sharma JA; Pandya DH; Pandya AN; Sudarsanam V; Vasu KK
    J Pharm Anal; 2014 Dec; 4(6):374-383. PubMed ID: 29403903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical method development, identification, and characterization of stress degradation products of idelalisib by ultrahigh-performance liquid chromatography with photodiode array and ultrahigh-performance liquid chromatography with electrospray ionization quadrupole time-of-flight mass spectrometry studies.
    Mahesh M; Bali A; Gupta T
    Rapid Commun Mass Spectrom; 2024 Jun; 38(11):e9745. PubMed ID: 38591150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential degradation products of abemaciclib: Identification and structural characterization employing LC-Q/TOF-MS and NMR including mechanistic explanation.
    Kathar N; Rajput N; Jadav T; Sengupta P
    J Pharm Biomed Anal; 2024 Jan; 237():115762. PubMed ID: 37844364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of seven new related impurities and forced degradation products of tetracaine hydrochloride and proposal of degradation pathway by UHPLC-Q-TOF-MS.
    Liu C; Luo Y; Tao Q; Hong L; Zeng S
    J Pharm Biomed Anal; 2023 Jan; 223():115116. PubMed ID: 36343535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of forced degradation products of tamsulosin using liquid chromatography/electrospray ionization tandem mass spectrometry.
    Namdev D; Borkar RM; Raju B; Kalariya PD; Rahangdale VT; Gananadhamu S; Srinivas R
    J Pharm Biomed Anal; 2014 Jan; 88():245-55. PubMed ID: 24083958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural elucidation of degradation products of a benzopyridooxathiazepine under stress conditions using electrospray orbitrap mass spectrometry - study of degradation kinetic.
    Lecoeur M; VĂ©rones V; Vaccher C; Bonte JP; Lebegue N; Goossens JF
    Eur J Pharm Sci; 2012 Apr; 45(5):559-69. PubMed ID: 22207039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification, characterization and in silico ADMET prediction of Roflumilast degradation products.
    Pinheiro MS; Viana GM; Vieira BA; de Souza AM; Rodrigues CR; Marins RC; Cabral LM; de Sousa VP
    J Pharm Biomed Anal; 2017 May; 138():126-133. PubMed ID: 28196344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of forced degradation products of 5-hydroxymethyl-2-furaldehyde (5-HMF) by HPLC, LC-LTQ/Orbitrap and NMR studies.
    Lu Y; Guo Y; Zhang Y; Sun H; Wu X
    J Pharm Biomed Anal; 2023 Sep; 233():115470. PubMed ID: 37210891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LC and LC-MS/MS studies for identification and characterization of degradation products of d-tubocurarine chloride.
    Grover P; Maheshwari S; Nagarajan K; Mehta L; Kumar S; Rastogi C
    J Pharm Biomed Anal; 2023 Jan; 223():115119. PubMed ID: 36343537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of stress degradation products of sumatriptan succinate by using LC/Q-TOF-ESI-MS/MS and NMR: Toxicity evaluation of degradation products.
    Udutha S; Shankar G; Borkar RM; Kumar K; Srinivasulu G; Guntuku L; Naidu VGM; Srinivas R
    J Mass Spectrom; 2018 Oct; 53(10):963-975. PubMed ID: 29987857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of validated stability indicating purity method based on the stress degradation behavior of gonadotropin-releasing hormone antagonist (ganirelix) in an injectable formulation using HPLC and LC-MS-QTOF.
    Ummiti K; Shanmukha Kumar JV
    Eur J Mass Spectrom (Chichester); 2021 Apr; 27(2-4):126-140. PubMed ID: 33823624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of forced degradation products of vortioxetine by LC/MS/MS and NMR.
    Ragi NC; Velma GR; Pallerla PK; Siddiqua S; Alugonda V; Rachamalla HKR; Pabbaraja S; Sripadi P
    J Pharm Biomed Anal; 2020 Sep; 188():113442. PubMed ID: 32622114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.